Security National Trust’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$245K Hold
1,000
0.06% 150
2021
Q2
$245K Hold
1,000
0.05% 155
2021
Q1
$265K Hold
1,000
0.06% 144
2020
Q4
$293K Hold
1,000
0.07% 135
2020
Q3
$236K Hold
1,000
0.07% 144
2020
Q2
$199K Hold
1,000
0.06% 151
2020
Q1
$184K Hold
1,000
0.07% 143
2019
Q4
$167K Hold
1,000
0.05% 173
2019
Q3
$131K Hold
1,000
0.04% 183
2019
Q2
$121K Hold
1,000
0.04% 189
2019
Q1
$123K Hold
1,000
0.04% 187
2018
Q4
$117K Hold
1,000
0.04% 182
2018
Q3
$125K Hold
1,000
0.04% 193
2018
Q2
$85K Hold
1,000
0.03% 229
2018
Q1
$60K Hold
1,000
0.02% 248
2017
Q4
$53K Hold
1,000
0.02% 259
2017
Q3
$56K Hold
1,000
0.02% 255
2017
Q2
$63K Hold
1,000
0.02% 258
2017
Q1
$51K Hold
1,000
0.02% 273
2016
Q4
$43K Hold
1,000
0.02% 288
2016
Q3
$47K Hold
1,000
0.02% 281
2016
Q2
$50K Buy
+1,000
New +$50.5K 0.02% 273

Other funds holding AMED

Security National Trust's AMED Position: Q3 2021 in Review

Security National Trust held its Amedisys (AMED) position steady in Q3 2021 at 1,000 shares worth $245K. The position accounts for 0.06% of the portfolio, ranked #150.

Security National Trust first reported a position in AMED in Q2 2016 and has held it in 22 quarters since. The position peaked at $293K in Q4 2020. 352 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Security National Trust held 1,000 shares of Amedisys worth $245K as of Q3 2021.
  • Security National Trust left its Amedisys share count unchanged in Q3 2021.
  • Amedisys made up 0.06% of Security National Trust's portfolio in Q3 2021, its #150 holding.
  • Security National Trust first reported a position in Amedisys in Q2 2016 and has held it in 22 quarters since.
  • Security National Trust's Amedisys position peaked at $293K in Q4 2020.
  • 352 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.